PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
11-Mar-2021 Oxford Instruments NanoScience Gains Momentum in Quantum Computing Businesswire
11-Mar-2021 Over Half of Financial Institutions Admit LIBOR Transition Plans Delayed by Covid-19 Businesswire
11-Mar-2021 UK Regulatory Announcement: Net Asset Value(s) Businesswire
11-Mar-2021 UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France Businesswire
11-Mar-2021 Genentech Provides Update on the Phase III REMDACTA Trial of Actemra Plus Veklury in Patients With Severe COVID-19 Pneumonia Businesswire
11-Mar-2021 Frontier Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering Businesswire
11-Mar-2021 Silver Spike Acquisition Corp II Announces Pricing of $250 Million Initial Public Offering Businesswire
11-Mar-2021 Sozosei Foundation Awards $75,000 in Grants to Local Texas Communities Impacted by Winter Storm Businesswire
11-Mar-2021 CWCI Study Examines California Workers’ Comp Pharmaceutical Trends Businesswire
10-Mar-2021 AVEO Announces Appointment of Mike Ferraresso to Chief Commercial Officer Businesswire
10-Mar-2021 Steel Connect Reports Second Quarter Financial Results Businesswire
10-Mar-2021 Eurofins lance empowerDX, son kit de test de la Covid-19 à domicile, sur Amazon Businesswire
10-Mar-2021 SQZ Biotech to Present Preclinical Data on KRAS Tumor Targets and Next Generation SQZ eAPCs at the American Association for Cancer Research (AACR) 2021 Annual Meeting Businesswire
10-Mar-2021 LAVA Therapeutics B.V. to Present Preclinical Findings Supporting Anti-Tumor Activity of Lead Clinical Candidate LAVA-051 at the American Association for Cancer Research (AACR) Virtual 2021 Annual Meeting Businesswire
10-Mar-2021 Takeda adquiere Maverick Therapeutics para promover los tratamientos de tumores sólidos con activadores de células T y ampliar la nueva cartera de inmunoterapia contra el cáncer Businesswire
10-Mar-2021 GlycoMimetics to Share GMI-1359 and Galectin-3 Antagonist Program Data at AACR 2021 Meeting Businesswire
10-Mar-2021 Dr. Elizabeth Nabel Rejoins Moderna’s Board of Directors Businesswire
10-Mar-2021 BeiGene Announces Presentation of Clinical and Preclinical Data at the AACR Annual Meeting 2021 Businesswire
10-Mar-2021 Invacare Corporation Proposed Offering of $100 Million Aggregate Principal Amount of Convertible Senior Notes Businesswire
10-Mar-2021 Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates Businesswire